Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Government and Public Sector Defence U.S. Homeland Security Pharmaceuticals & Chemicals R&D -Programs and Funding Opportunities
Publications

(Currently 512486 Items)


Partners


Defence / REPORT INFORMATION

U.S. Homeland Security Pharmaceuticals & Chemicals R&D -Programs and Funding Opportunities

DateFeb, 2006
Pages0
Price / format$3950 / PDF by E-mail Single User License

$3 950 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:

Table of Contents

  • 1. Executive Summary
    • 1.1. Introduction
    • 1.2. Basic Scenario Assumptions
    • 1.3. Methodology
    • 1.4. Major Research Findings
      • 1.4.1. U.S. HLS Pharmaceuticals R&D Budget Forecast --2006--2010
      • 1.4.2. U.S. HLS Pharmaceuticals R&D Market Forecast --2006--2010
    • 1.5. Major Research Conclusions
  • 2. U.S. HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
    • 2.1. U.S. HLS R&D Structure
      • 2.1.1. Definitions
    • 2.2. U.S. HLS Pharmaceuticals R&D -- Participating Agencies & Funding --2006--2010
    • 2.3. U.S. HLS Pharmaceuticals R&D Outlay Overview -- 2006 -- 2010
    • 2.4. U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
    • 2.5. U.S. HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 2.6. U.S. HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 3. DHHS -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
    • 3.1. NIH (DHHS) -- Homeland Security Mission
    • 3.2. CDC (DHHS) -- Homeland Security Mission
    • 3.3. FDA (DHHS) -- Homeland Security Mission
    • 3.4. DHHS -- HLS Pharmaceuticals R&D Program Summary & Budget Forecast -- 2006-2010
      • 3.4.1. DHHS -- HLS Pharmaceuticals R&D Budget Forecast by Application -- 2006--2010
    • 3.5. DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
    • 3.6. DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 3.7. DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 4. DOD -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
    • 4.1. DOD -- General Structure of R&D Budget & Fund Allocations
    • 4.2. DOD -- R&D Policy Making Hierarchy
    • 4.3. U.S. ARMY -- R&D Funding Agencies
      • 4.3.1. U.S. ARMY Research Office (ARO)
      • 4.3.2. U.S. ARMY Research Laboratory (ARL)
    • 4.4. DOD -- Defense Advanced Research Projects Agency (DARPA)
    • 4.5. DOD -- Chemical and Biological Defense Program (CBDP)
    • 4.6. DOD -- HLS Pharmaceuticals R&D Program Summary & Budge Forecast -- 2006--2010
      • 4.6.1. DOD -- HLS Pharmaceuticals R&D Budget Forecast by Application -- 2006--2010
      • 4.6.2. DOD -- HLS Pharmaceuticals R&D Budget Forecast by Agency -- 2006--2010
    • 4.7. DOD -- HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
    • 4.8. DOD -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 4.9. DOD -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 5. DHS -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
    • 5.1. Outline and Resources
    • 5.2. DHS -- Science & Technology Division (S&T)
    • 5.3. S&T Directorate -- Major Groups
      • 5.3.1. DHS -- Office of Programs Plans & Budgets (PPB)
      • 5.3.2. DHS -- Homeland Security Advanced Research Project Agency (HSARPA)
      • 5.3.3. DHS -- Office of R&D
      • 5.3.4. DHS -- Office of Systems Engineering and Development(SED)
    • 5.4. DHS -- HLS Pharmaceuticals R&D Program Summary & Budget Forecast -- 2006--2010
    • 5.5. DHS -- Instrumentation R&D Budget Forecast by Application --2006--2010
    • 5.6. DHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
      • 5.6.1. Allocation to Private, Academia & Government Sectors --2006 -- 2010
    • 5.7. DHS -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 5.8. DHS -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 6. DOE -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
    • 6.1. DOE -- HLS R&D Sources
    • 6.2. DOE -- HLS Pharmaceuticals R&D Program Summary & BudgetForecast -- 2006--2010
    • 6.3. DOE -- HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
    • 6.4. DOE -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 6.5. DOE -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 7. USDA -- HLS Pharmaceuticals R&D Funding Opportunities-- 2006 -- 2010
    • 7.1. USDA -- HLS R&D Sources
    • 7.2. USDA -- HLS Pharmaceuticals R&D Program Summary & Budget Forecast -- 2006--2010
    • 7.3. USDA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
    • 7.4. USDA -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 7.5. USDA -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 8. EPA -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
    • 8.1. EPA -- HLS R&D Sources
    • 8.2. EPA -- HLS Pharmaceuticals R&D Program Summary & Budget Forecast -- 2006--2010
      • 8.2.1. EPA -- HLS Pharmaceuticals R&D Budget Forecast by Application -- 2006--2010
    • 8.3. EPA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast --2006--2010
    • 8.4. EPA -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 8.5. EPA -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors --2006--2010
  • 9. Biological Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 9.1. Summary & Outlook
      • 9.1.1. DHHS -- Biological Therapeutics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 9.1.2. DOD -- Biological Therapeutics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
    • 9.2. Biological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006 -- 2010
    • 9.3. Biological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006--2010
    • 9.4. Biological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006--2010
    • 9.5. -- 9.7. Biological Therapeutics HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 10. Vaccines -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 10.1. Summary & Outlook
    • 10.2. Vaccines -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments -- 2006--2010
      • 10.2.1. DHHS -- Vaccines HLS Pharmaceuticals R&D
      • 10.2.2. DOD -- Vaccines HLS Pharmaceuticals R&D
    • 10.3. Vaccines -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006--2010
    • 10.4. Vaccines -- HLS Pharmaceuticals R&D Funding Opportunities Drivers --2006--2010
    • 10.5. Vaccines -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006--2010
    • 10.6. -- 10.8. Vaccines HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 11. Chemical Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 11.1. Summary & Outlook
    • 11.2. DOD -- Chemical Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
    • 11.3. Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006 -- 2010
    • 11.4. Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006 -- 2010
    • 11.5. Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006 -- 2010
    • 11.6. Chemical Therapeutics -- HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 12. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 12.1. Summary & Outlook
    • 12.2. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D by Major Departments Forecast -- 2006--2010
      • 12.2.1. NIH (DHHS) -- Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 12.2.2. DOD -- Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 12.2.3. DOE -- Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
    • 12.3. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006--2010
    • 12.4. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006--2010
    • 12.5. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006--2010
    • 12.6. -- 12.8. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 13. Decontamination -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 13.1. Summary & Outlook
    • 13.2. Decontamination -- HLS Pharmaceuticals R&D by Major Departments Forecast -- 2006--2010
      • 13.2.1. EPA -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 13.2.2. DOD -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 13.2.3. DHS -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 13.2.4. DOE -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 13.2.5. TSWG -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
    • 13.3. Decontamination -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006--2010
    • 13.4. Decontamination -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006--2010
    • 13.5. Decontamination HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006--2010
    • 13.6. -- 13.12. Decontamination HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 14. Diagnostics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 14.1. Summary & Outlook
    • 14.2. Diagnostics -- HLS Pharmaceuticals R&D by Major Departments Budget Forecast -- 2006--2010
      • 14.2.1. DHHS -- Diagnostics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 14.2.2. DOD -- Diagnostics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
    • 14.3. Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006--2010
    • 14.4. Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006--2010
    • 14.5. Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006--2010
    • 14.6. -- 14.9. Diagnostics HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 15. Food Protection Treatments -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 15.1. Summary & Outlook
    • 15.2. Food Protection Treatments -- HLS Pharmaceuticals R&D by Major Departments Forecast -- 2006--2010
      • 15.2.1. DHHS -- Food Protection Treatments HLS Pharmaceuticals R&D Forecast -- 2006--2010
      • 15.2.2. USDA -- Food Protection Treatments HLS Pharmaceuticals R&D Forecast -- 2006--2010
      • 15.2.3. DHS -- Food Protection Treatments HLS Pharmaceuticals R&D Forecast -- 2006--2010
    • 15.3. Food Protection Treatments -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006--2010
    • 15.4. Food Protection Treatments -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006--2010
  • 16. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
    • 16.1. Summary & Outlook
    • 16.2. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments-- 2006--2010
      • 16.2.1. DHHS -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 16.2.2. DOD -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 16.2.3. DHS - Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • 16.2.4. NSF -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
    • 16.3. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Forecast -- 2006--2010
    • 16.4. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Drivers -- 2006--2010
    • 16.5. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Inhibitors -- 2006--2010
    • 16.6. -- 16.11. Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Programs, Grants and Business Opportunities -- 2006 -- 2010
  • 17. Investing In HLS Technology
    • 17.1. A Word of Caution
    • 17.2. HLS Industry Experts
    • 17.3. Competitive Intelligence
    • 17.4. A Second Opinion
  • Appendix A: The Homeland Security Federal R&D Infrastructure
    • A.1. SBIR funding (Small Business Innovations Research)
    • A.2. Small Business Technology Transfer (STTR) program R&D funding
  • List of Figures
    • 1. Executive Summary
      • Figure 1 -- U.S. HLS Pharmaceuticals R&D Budget Forecast by Application [$B] --2006--2010.
      • Figure 2 -- U.S. HLS Pharmaceuticals R&D Budget Forecast by Application Share -- 2004, 2006 & 2010.
      • Figure 3 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$B] -- 2006--2010
      • Figure 4 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
    • 2. U.S. HLS Pharmaceuticals R&D Funding Oppertunities -2006 - 2010
      • Figure 5 - Overview of Entire Homeland Security and Homeland Defense Infrastructure
      • Figure 6 - US Federal HLS Pharmaceuticals R&D Budget Forecast by Agency [$B] -- 2006--2010
      • Figure 7 --Federal HLS Pharmaceuticals R&D Budget Forecast by Agency Share -- 2004, 2006 & 2010
      • Figure 8 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$B] -- 2006--2010
      • Figure 9 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 10 -- U.S. HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$B] -- 2006--2010
      • Figure 11 -- U.S. HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$B] -- 2006--2010
      • Figure 12 -- U.S. HLS Pharmaceuticals R&D Government Funding Opportunities Forecast [$B] -- 2006--2010
    • 3. DHHS -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Figure 13 - DHHS -- HLS Pharmaceuticals R&D Budget Forecast by Application [$B] -- 2006--2010
      • Figure 14 - DHHS -- HLS Pharmaceuticals R&D Budget Forecast by Application Share -- 2004, 2006 & 2010
      • Figure 15 - DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$B] -- 2006--2010
      • Figure 16 - DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 17 - DHHS -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 18 - DHHS -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 19 - DHHS -- HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 4. DOD -- HLS Pharmaceuticals R&D Funding Opportunities-- 2006 -- 2010
      • Figure 20 - DOD -- R&D Oversight and Funding Allocation
      • Figure 21 - DOD -- Historical Trends in Defense R&D [$B] -- 2000 -- 2006
      • Figure 22 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Application [$M] -- 2006--2010
      • Figure 23 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Application -- 2004, 2006 & 2010
      • Figure 24 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Agency [$M] -- 2006--2010
      • Figure 25 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Agency Share -- 2004, 2006 & 2010
      • Figure 26 - DOD -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 27 - DOD -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 28 - DOD -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 29 - DOD -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 30 - DOD -- HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 5. DHS -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Figure 31 - DHS -- Science and Technology Division (S&T) -- Organizational Chart
      • Figure 32 - DHS -- HLS Pharmaceuticals R&D Budget Forecast by Application [$B] -- 2006--2010
      • Figure 33 - DHS -- HLS Pharmaceuticals R&D Budget Forecast by Application Share -- 2004, 2006 & 2010
      • Figure 34 - DHS --HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$B] -- 2006--2010
      • Figure 35 - DHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 36 - DHS -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 37 - DHS -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 38 - DHS -- HLS Pharmaceuticals R&D Government Funding Opportunities Forecast [$M] -- 2006--2010
    • 6. DOE -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Figure 39 - DOE -- HLS Pharmaceuticals R&D Funding Summary Forecast [$M] --2006--2010
      • Figure 40 - DOE -- HLS Pharmaceuticals R&D Budget Forecast by Application Share -- 2004, 2006 & 2010
      • Figure 41 - DOE -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 42 - DOE -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 43 - DOE -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 44 - DOE -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 45 - DOE -- HLS Pharmaceuticals R&D Government Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 46 - USDA -- Food and Water Treatment R&D Budget Forecast [$B] -- 2006--2010
      • Figure 47 - USDA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
    • 7. USDA -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Figure 48 - USDA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 49 - USDA -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 50 - USDA -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 51 - USDA -- HLS Pharmaceuticals R&D Government Funding Opportunities Forecast [$M] -- 2006--2010
    • 8. EPA -- HLS Pharmaceuticals R&D Funding Opportunities-- 2006 -- 2010
      • Figure 52 - EPA -- Decontamination R&D Budget Forecast [$M] -- 2006--2010
      • Figure 53 - EPA --HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 54 - EPA --HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 55 - EPA --HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 56 - EPA -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 57 - EPA -- HLS Pharmaceuticals R&D Government Funding Opportunities Forecast [$M] -- 2006--2010
    • 9. Biological Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 58 - Biological Therapeutics HLS R&D Budget Forecast by Major Departmentss -- 2006--2010
      • Figure 59 - Biological Therapeutics HLS R&D Budget Forecast by Major Departmentss Share -- 2004, 2006 & 2010
      • Figure 60 - DHHS -- Biological Therapeutics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 61 - DOD -- Biological Therapeutics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 62 - Biological Therapeutics HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 63 - Biological Therapeutics HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 64 - Biological Therapeutics HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 65 - Biological Therapeutics HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 66 - Biological Therapeutics HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 10. Vaccines -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 71 - Vaccines HLS R&D Budget Forecast by Major Departments [$B] -- 2006--2010
      • Figure 72 - Vaccines HLS R&D Budget Forecast by Major Departments Share -- 2004, 2006 & 2010
      • Figure 73 - DHHS -- Vaccines HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 74 - DOD -- Vaccines HLS Pharmaceuticals R&D Budget Forecast [$M]-- 2006--2010
      • Figure 75 - Vaccines HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$B] -- 2006--2010
      • Figure 76 - Vaccines HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 77 - Vaccines HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 78 - Vaccines HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 79 - Vaccines HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 11. Chemical Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 91 - DOD -- Chemical Therapeutics HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 92 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 93 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 94 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 95 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 96 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 12. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Programsand Funding Opportunities Forecast -- 2006--2010
      • Figure 110 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [$B] -- 2006--2010
      • Figure 111 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments Share -- 2004, 2006 & 2010
      • Figure 112 - NIH (DHHS) -- Nuclear/Radiological Countermeasures HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 113 - DOD -- Nuclear/Radiological Countermeasures HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 114 - DOE -- Nuclear/Radiological Countermeasures HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 115 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 116 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector --2004, 2006 & 2010
      • Figure 117 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 118 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] --2006--2010
      • Figure 119 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] --2006--2010.
    • 13. Decontamination -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 124 - Decontamination -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [$M] -- 2006--2010
      • Figure 125 - Decontamination-- HLS Pharmaceuticals R&D Budget Forecast by Major Departments Share -- 2004, 2006 & 2010
      • Figure 126 - EPA -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 127 - DOD -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 128 - DHS -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 129 - DOE -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 130 - TSWG -- Decontamination HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 131 - Decontamination HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 132 - Decontamination HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 133 - Decontamination HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 134 - Decontamination HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 135 - Decontamination HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 14. Diagnostics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 148 - Diagnostics -- HLS Pharmaceuticals R&D by Major Departments Budget Forecast [$M] -- 2006--2010
      • Figure 149 - Diagnostics -- HLS Pharmaceuticals R&D by Major Departments Budget Forecast Share -- 2004, 2006 & 2010
      • Figure 150 - DHHS -- Diagnostics HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 151 - DOD -- Diagnostics HLS Pharmaceuticals R&D Budget Forecast -- 2006--2010
      • Figure 152 - Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 153 - Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 154 - Diagnostics -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 155 - Diagnostics -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 156 - Diagnostics -- HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 15. Food Protection Treatments -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 166 - Food Protection Treatments HLS Pharmaceuticals R&D by Major Departments Forecast -- 2006--2010
      • Figure 167 - Food Protection Treatments HLS Pharmaceuticals R&D by Major Departments Forecast Share -- 2004, 2006 & 2010
      • Figure 168 - DHHS -- Food Protection Treatments HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 169 - USDA -- Food Protection Treatments HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 170 - DHS -- Food Protection Treatments HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 171 - Food Protection Treatments -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 172 - Food Protection Treatments -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 173 - Food Protection Treatments -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 174 - Food Protection Treatments -- HLS Pharmaceuticals R&D Academia Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 16. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Figure 177 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [$M] -- 2006--2010
      • Figure 178 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Budget Forecast by Major DepartmentsShare -- 2004, 2006 & 2010
      • Figure 179 - DHHS -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 180 - DOD -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 181 - DHS -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 182 - NSF -- Treatment for Emerging Biochemical Threats HLS Pharmaceuticals R&D Budget Forecast [$M] -- 2006--2010
      • Figure 183 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Figure 184 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector -- 2004, 2006 & 2010
      • Figure 185 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Private Sector Funding Opportunities Forecast [$M] -- 2006--2010
      • Figure 186 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Academia Sector Funding OpportunitiesForecast [$M] -- 2006--2010
      • Figure 187 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Government Sector Funding Opportunities Forecast [$M] -- 2006--2010
    • 17. Investing In HLS Technology
      • Figure 190 -- Homeland Security Federal R&D General Structure
  • List of Tables
    • 1. Executive Summary
      • Table 1 - HLS Pharmaceuticals R&D - Participating Agencies Funding for FY 2006 [$M]
      • Table 2 - U.S. HLS Pharmaceuticals R&D Budget Forecast by Application [$M] --2006--2010
      • Table 3 - U.S. HLS Pharmaceuticals R&D Budget Forecast by Application [%] --2006--2010
      • Table 4 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 5 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector Share [%] -- 2006--2010
      • 2. U.S. HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 6 - Major S&T Initiatives in the National Strategy for Homeland Security
      • Table 7 - HLS Pharmaceuticals R&D - Participating Agencies and Programs for FY 2006-2010
      • Table 8 -- U.S. Federal HLS Pharmaceuticals R&D Budget Forecast by Agency [$M] -- 2006--2010
      • Table 9 - US Federal HLS Pharmaceuticals R&D Budget Forecast by Agency Share [%] -- 2006--2010
      • Table 10 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 11 - U.S. HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector Share [%] -- 2006--2010
    • 3. DHHS -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 12 - DHHS -- HLS Pharmaceuticals R&D Budget Forecast by Application [$M] -- 2006--2010
      • Table 13 - DHHS -- HLS Pharmaceuticals R&D Budget Forecast by Application Share [%] -- 2006--2010
      • Table 14 - DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 15 - DHHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 4. DOD -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 16 - DOD -- Research, Development, Test & Evaluation by Agency [$B] -- 2004--2006
      • Table 17 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Application [$M] -- 2006--2010
      • Table 18 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Application Share [%] -- 2006--2010
      • Table 19 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Agency [$M] -- 2006--2010
      • Table 20 - DOD -- HLS Pharmaceuticals R&D Budget Forecast by Agency Share [%] -- 2006--2010
      • Table 21 - DOD -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 22 - DOD -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 5. DHS -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 23 - DHS -- HLS Pharmaceuticals R&D Budget Forecast by Application [$M] -- 2006--2010
      • Table 24 - DHS -- HLS Pharmaceuticals R&D Budget Forecast by Application Share [%] -- 2006--2010
      • Table 25 - DHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 26 - DHS -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 6. DOE -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 27 - DOE -- HLS Pharmaceuticals R&D Funding Summary Forecast [$M] -- 2006--2010
      • Table 28 - DOE -- HLS Pharmaceuticals R&D Funding Summary Forecast Share [%] -- 2006--2010
      • Table 29 - DOE -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 30 - DOE -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 7. USDA -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 31 - USDA -- HLS Pharmaceuticals R&D Funding Opportunities Foreca by Sector [$M] -- 2006--2010
      • Table 32 - USDA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 8. EPA -- HLS Pharmaceuticals R&D Funding Opportunities -- 2006 -- 2010
      • Table 33 - EPA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 34 - EPA -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 9. Biological Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 35 - Biological Therapeutics HLS R&D Budget Forecast by Major Departmentss -- 2006--2010
      • Table 36 - Biological Therapeutics HLS R&D Budget Forecast by Major Departmentss -- 2006--2010
      • Table 37 - Biological Therapeutics HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 38 - Biological Therapeutics HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 10. Vaccines -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 39 - Vaccines HLS R&D Budget Forecast by Major Departments [$M] -- 2006--2010
      • Table 40 - Vaccines HLS R&D Budget Forecast by Major Departments [%] -- 2006--2010
      • Table 41 - Vaccines HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 42 - Vaccines HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 11. Chemical Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 43 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 44 - Chemical Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 12. Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 45 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [$M] -- 2006--2010
      • Table 46 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [%] -- 2006--2010
      • Table 47 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 48 - Nuclear/Radiological Therapeutics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 13. Decontamination -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 49 - Decontamination -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [$M] -- 2006--2010
      • Table 50 - Decontamination -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [%] -- 2006--2010
      • Table 51 - Decontamination HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010 Forecast Share by Sector [%] -- 2006--2010
    • 14. Diagnostics -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 53 - Diagnostics -- HLS Pharmaceuticals R&D by Major Departments Budget Forecast [$M] -- 2006--2010
      • Table 54 - Diagnostics -- HLS Pharmaceuticals R&D by Major Departments Budget Forecast Share [%] -- 2006--2010
      • Table 55 - Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 56 - Diagnostics -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 15. Food Protection Treatments -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 57 - Food Protection Treatments HLS Pharmaceuticals R&D by Major Departments Forecast [$M] -- 2006--2010
      • Table 58 - Food Protection Treatments HLS Pharmaceuticals R&D by Major Departments Forecast Share [%] -- 2006--2010
      • Table 59 - Food Protection Treatments -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 60 - Food Protection Treatments -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • 16. Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Programs and Funding Opportunities Forecast -- 2006--2010
      • Table 61 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments [$M] -- 2006--2010
      • Table 62 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Budget Forecast by Major Departments Share [%] -- 2006--2010.
      • Table 63 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Forecast by Sector [$M] -- 2006--2010
      • Table 64 - Treatment for Emerging Biochemical Threats -- HLS Pharmaceuticals R&D Funding Opportunities Forecast Share by Sector [%] -- 2006--2010
    • Appendix A: The Homeland Security Federal R&D Infrastructure
      • Table 65 - Small Business Innovation Research Program -- FY2006
      • Table 66 - Small Business Technology Transfer Program -- FY2006







Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com